We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong at PhilMedical 2023 Expo | More to Expect!

By LabMedica International staff writers
Posted on 19 Sep 2023
From 23 to 25 August 2023, the MEDICAL PHILIPPINES 2023 Expo was held at the SMX Convention Center in Manila, Philippines. More...
As the largest and most professional medical devices expo in Philippines, it attracted the participation of many famous companies in the industry. As an innovative leader in the field of molecular diagnostics in China, Tianlong Technology showcased its advanced technology, products and solutions, as well as professional services on this expo.

At the exhibition, Tianlong’s Panall 8000 All-in-one Molecular Diagnosis System, which can realize "joint detection of multiple pathogens", the compact and flexible Gentier Mini Series Portable Real Time PCR System, as well as the GeneFlex Automatic Nucleic Acid Extractor, received wide attention from the visitors.

On the first day of the expo, the head of Department of Emergency Medical and Trauma Services, Hospital Kuala Lumpur visited Tianlong’s booth and had a deep communication with Tianlong processionals. Hospital Kuala Lumpur is now the largest hospital under the Ministry of Health of Malaysia and is considered to be one of the biggest hospital in Asia.

During the expo, Tianlong's professional team had deep communication with customers, introducing and demonstrating product features, technical advantages and service system.

Tianlong not only achieved good attention on the exhibition, but also developed cooperation opportunities, opening up new channels and opportunities for the future development of the enterprise.

The successful participation in the expo is also an important step in Tianlong's globalization strategy. As an enterprise actively expanding overseas markets, Tianlong will continue to look at the global market and work with more international partners to promote the development of medical technology.

Stay tuned for Tianlong’s following two expos in Thailand this coming September!

Thailand LAB International
Booth No. 3G17
Dates: Sep 6 to 8, 2023
Venue: BITEC, Bangkok, Thailand

Medical Fair Thailand
Booth No. T05
Dates: Sep 13 to 15, 2023
Venue: BITEC, Bangkok, Thailand



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.